EUVIMEDEUVIMED entdecken
BeobachtungsstudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study

Dakota Redling, Shannon Bialak, Laure El Ghormli iD, Steven D Chernausek iD, Kenneth Jones, Jeanie B Tryggestad iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae376 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Dakota Redling und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Circulating MicroRNA, Insulin-Secreting Cells, Glycated Hemoglobin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study, an intervention trial followed by an observational phase, half the participants reached the primary outcome [hemoglobin A1c (HbA1c) ≥ 8% for at least 6 months] within 4 years, which was associated with a decrease in C-peptide oral disposition index (oDI). We aimed to identify circulating microRNA (miRNA) species associated with a decline in beta cell function.

Methods

Following a preliminary survey of select participants using nCounter Human v3 miRNA Panel (NanoString Technologies), polymerase chain reaction analyses were carried out for 17 miRNAs from 365 participants from samples at baseline, 24, 60, 96, and 120 months.

Results

Using a backward selection approach, 4 baseline miRNA log2 fold-changes independently predicted treatment failure; however, baseline HbA1c was higher in those with treatment failure. Three baseline miRNA log2 fold-changes remained significant predictors of this C-peptide oDI decline ≥20% (P < .05). Increased levels of miRNA-155 [odds ratio (OR): 1.2, 95% confidence interval (CI): 1.1-1.4] and miRNA-130b (OR:1.3, 95% CI: 1.0-1.7) were associated with oDI decline, while decreased levels of miRNA-126 (OR: 0.6, 95% CI: .4-.8) were associated with oDI decline. miRNA-122 was negatively correlated with C-peptide oDI at baseline and 24 months (R = 0.22, P < .01 and R = 0.19, P < .01, respectively) and positively correlated with proinsulin at baseline, 24, and 60 months (R = 0.26, P < 0.01, R = 0.26, P < .01, R = 0.18, P < .01, respectively).

Conclusion

The miRNA species associated with beta cell function are associated with alterations in cellular metabolism and apoptosis, suggesting that differences in baseline abundance may serve as circulating markers of beta cell dysfunction and provide potential mechanistic insights into the aggressive nature of youth-onset type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Circulating MicroRNAInsulin-Secreting CellsGlycated HemoglobinHumansFemaleMaleAdolescentBiomarkersChildC-PeptideMicroRNAsHypoglycemic AgentsAge of OnsetPrognosisYoung Adult

Stichwörter der Autor:innen

beta cell functionmiRNAyouth-onset type 2 diabetes

Substanzen

Circulating MicroRNAGlycated HemoglobinBiomarkershemoglobin A1c protein, humanC-PeptideMicroRNAsHypoglycemic Agents

Autor:innen und Institutionen

  • University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • The Biostatistics Center, George Washington University, Rockville, MD 20852, USA.

ORCID-Profile: Laure El Ghormli, Steven D Chernausek, Jeanie B Tryggestad

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Redling, D., Bialak, S., El Ghormli, L., Chernausek, S. D., Jones, K., & Tryggestad, J. B. (2024). Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae376

Vancouver

Redling D, Bialak S, El Ghormli L, Chernausek SD, Jones K, Tryggestad JB. Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae376

BibTeX
@article{Redling2024,
  author = {Redling, Dakota and Bialak, Shannon and El Ghormli, Laure and Chernausek, Steven D and Jones, Kenneth and Tryggestad, Jeanie B},
  title = {Circulating MicroRNAs as Predictors of Beta Cell Function in Youth-onset Type 2 Diabetes: The TODAY Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae376}
}
Kostenlos starten →